How does Nucore compare to other ethical investing tools and conventional screening platforms?
| Feature | Nucore Systems $99–$999/mo |
Generic Screeners Free–$50/mo |
Manual Research DIY |
Conventional Quant $200+/mo |
|---|---|---|---|---|
| AAOIFI-aligned screening | ✓ Full 4-layer | Partial | Manual only | Not offered |
| Algorithmic buy/sell signals | ✓ Daily signals | ✗ | ✗ | ✓ (no ethics) |
| Backtesting laboratory | ✓ Full fidelity | ✗ | ✗ | ✓ (no ethics) |
| Charitable allocation tools | ✓ Automated | ✗ | ✗ | ✗ |
| Compliance audit logs | ✓ Full audit trail | ✗ | ✗ | Basic |
| No short-selling guardrails | ✓ Enforced | Not enforced | User dependent | Shorts allowed |
| No margin / leverage | ✓ Enforced | Not enforced | User dependent | Leverage used |
| Screening re-run frequency | Daily | Quarterly | Ad hoc | Daily (no ethics) |
| Data retention after lapse | 90–180 days | Immediate delete | N/A | Varies |
| No auto-charge on lapse | ✓ Guaranteed | Often auto-renews | N/A | Often auto-renews |
| API access | Institutional tier | ✗ | ✗ | ✓ |
| White-label options | Institutional tier | ✗ | ✗ | ✗ |
| Illustrative backtest disclosed | ✓ 4,433% net | None disclosed | N/A | Varies |
Comparison is general and representative. Competitor features vary. Verify independently before making decisions.
No other platform combines AAOIFI-aligned ethical screening with institutional-grade algorithmic signals, backtesting, charitable allocation, and an investor-friendly lapse policy — at any price.